欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Orgyia pseudotsugata multicapsid polyhedrosis virus Probable DNA-directed RNA polymerase subunit beta (LEF-8), partial CSB-YP522535OEU
CSB-EP522535OEU
CSB-BP522535OEU
CSB-MP522535OEU
CSB-EP522535OEU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Red-sensitive opsin (opn1lw1), partial CSB-YP522536XBE1
CSB-EP522536XBE1
CSB-BP522536XBE1
CSB-MP522536XBE1
CSB-EP522536XBE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oncorhynchus mykiss Fatty acid-binding protein, heart (fabp3) CSB-YP522537OEI
CSB-EP522537OEI
CSB-BP522537OEI
CSB-MP522537OEI
CSB-EP522537OEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protobothrops flavoviridis Snake venom serine protease 2 (TLF2) CSB-YP522538EZB
CSB-EP522538EZB
CSB-BP522538EZB
CSB-MP522538EZB
CSB-EP522538EZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trimeresurus gramineus Snake venom serine protease 2C (TLG2C) CSB-YP522539TQK
CSB-EP522539TQK
CSB-BP522539TQK
CSB-MP522539TQK
CSB-EP522539TQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Protein atonal homolog 7-B (atoh7-b) CSB-YP522540XBE
CSB-EP522540XBE
CSB-BP522540XBE
CSB-MP522540XBE
CSB-EP522540XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chicken Avidin-related protein 1 (AVR1) CSB-YP522541CH
CSB-EP522541CH
CSB-BP522541CH
CSB-MP522541CH
CSB-EP522541CH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Protein groucho-1 (gro1), partial CSB-YP522542DIL
CSB-EP522542DIL
CSB-BP522542DIL
CSB-MP522542DIL
CSB-EP522542DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Poeciliopsis lucida Heat shock protein beta-1 (hspb1) CSB-YP522543EXK
CSB-EP522543EXK
CSB-BP522543EXK
CSB-MP522543EXK
CSB-EP522543EXK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe WD repeat-containing protein srw1 (srw1), partial CSB-YP522544SXV
CSB-EP522544SXV
CSB-BP522544SXV
CSB-MP522544SXV
CSB-EP522544SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida tropicalis Isocitrate dehydrogenase [NADP] peroxisomal (IDP2) CSB-YP522545CZN
CSB-EP522545CZN
CSB-BP522545CZN
CSB-MP522545CZN
CSB-EP522545CZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Scheffersomyces stipitis Alcohol dehydrogenase 2 (ADH2) CSB-YP522546SXM
CSB-EP522546SXM
CSB-BP522546SXM
CSB-MP522546SXM
CSB-EP522546SXM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Inositol phosphorylceramide synthase (AUR1), partial CSB-YP522547CZD
CSB-EP522547CZD
CSB-BP522547CZD
CSB-MP522547CZD
CSB-EP522547CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant O-methylsterigmatocystin oxidoreductase (ordA), partial CSB-YP522548DPB
CSB-EP522548DPB
CSB-BP522548DPB
CSB-MP522548DPB
CSB-EP522548DPB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptococcus neoformans var. grubii Chitin synthase 1 (CHS1), partial CSB-YP522549DYM
CSB-EP522549DYM
CSB-BP522549DYM
CSB-MP522549DYM
CSB-EP522549DYM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ATP-dependent RNA helicase ded1 (ded1), partial CSB-YP522550SXV
CSB-EP522550SXV
CSB-BP522550SXV
CSB-MP522550SXV
CSB-EP522550SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ustilago maydis Chitin synthase 5 (CHS5), partial CSB-YP522551UBS
CSB-EP522551UBS
CSB-BP522551UBS
CSB-MP522551UBS
CSB-EP522551UBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Phenylalanine--tRNA ligase beta subunit (FRS1), partial CSB-YP522552CZF
CSB-EP522552CZF
CSB-BP522552CZF
CSB-MP522552CZF
CSB-EP522552CZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kluyveromyces lactis Histidine biosynthesis trifunctional protein (HIS4), partial CSB-YP522553KBK
CSB-EP522553KBK
CSB-BP522553KBK
CSB-MP522553KBK
CSB-EP522553KBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kluyveromyces lactis Octanoyltransferase, mitochondrial (LIPB), partial CSB-YP522554KBK
CSB-EP522554KBK
CSB-BP522554KBK
CSB-MP522554KBK
CSB-EP522554KBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×